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ABSTRACT: Transition-metal catalysis is a powerful tool for the 
construction of chemical bonds. Here we show that a non-heme 
iron enzyme can catalyze olefin aziridination and nitrene C–H in-
sertion, and that these activities can be improved by directed evo-
lution. The non-heme iron center allows for facile modification of 
the primary coordination sphere by addition of metal-coordinating 
molecules, enabling control over enzyme activity and selectivity 
using small molecules. 
Over the last century, chemists have developed myriad synthetic 
transition-metal catalysts to access new chemical transformations 
and modes of reactivity. Nature has been developing catalysts for 
far longer: over billions of years, she has evolved a rich repertoire 
of proteins that perform most of the chemical reactions of life. But 
nature’s inventions do not include many of the best inventions of 
human chemists. Our efforts to merge abiological transition-metal 
chemistry with nature’s vast toolbox of metalloproteins have fo-
cused on heme-binding proteins1, as the heme cofactor and its ana-
logues are well-studied in synthetic transition-metal chemistry. 
However, heme-binding proteins represent only a small fraction of 
the chemical diversity present in natural metalloproteins. Metallo-
proteins comprise greater than 30% of all proteins2 and are respon-
sible for some of the most fundamental chemical reactions in biol-
ogy, including nitrogen fixation, photosynthesis, and DNA synthe-
sis. Natural metalloproteins bind a variety of metals in a wide range 
of metal-binding sites, either coordinating the metal ion itself or a 
more complex metal-containing cofactor. Nearly any heteroatom-
containing side chain can coordinate to a metal, in addition to the 
peptide backbone, allowing myriad possible coordination environ-
ments3. Many coordination environments in non-heme metalloen-
zymes have multiple open coordination sites at the metal center, a 
key feature of numerous synthetic transition-metal catalysts. Ex-
panding new-to-nature catalysis to non-heme metalloenzymes 
would open a new world of transition-metal biocatalysis.  
For decades, humans have used small-molecule ligands to un-
derstand and control Nature’s catalysts. Nature employs allostery 
to regulate enzyme activity with small molecules (Figure 1A). Al-
losteric regulation of enzymes has been studied at length4 and there 
have been successful examples of engineered5 or designed6 allo-
steric enzyme regulation, but allostery is still challenging to under-
stand or adapt to engineered systems. Cofactor-dependent en-
zymes, in which a small molecule is directly involved in catalysis, 
are often more readily understood and more easily manipulated by 
small molecules. Biochemists have knocked out catalytic activity 
via mutagenesis and restored it with exogenous effectors7 and sub-
stituted native cofactors with synthetic analogues with altered prop-
erties8. In the case of heme-binding proteins, scientists have substi-
tuted the metal ion9 or modified the porphyrin prosthetic group10 to 
modulate or expand enzymatic activity. A non-heme metallopro-
tein, in which a metal ion is coordinated directly by the protein and 
by exogenous small molecules, would allow for direct manipula-
tion of the primary metal coordination environment. 
 
Figure 1. Examples of enzyme activity control using small mole-
cules. (A) ADP acts as a natural allosteric regulator of phosphofruc-
tokinase (PDB ID: 4PFK). (B) Non-natural analogues of ATP act 
as competitive inhibitors of ATP-dependent enzymes (PDB ID: 
1I5A).  (C) This work: small-molecule activation of a non-heme 
iron center for nitrene transfer.   
 
To search for abiological catalytic promiscuity among natural 
metalloproteins, we looked at α-ketoglutarate (αKG)-dependent 
iron enzymes, a family of enzymes which features a conserved 
metal-binding active site with iron coordinated by two histidines 
and one aspartate or glutamate11. In nature, these enzymes perform 
similar chemistry to the heme-binding cytochrome P450 family, in 
which a high-valent iron-oxo intermediate performs C–H hydrox-
ylation, olefin epoxidation, or other oxidative transformations12. 
Though members of this enzyme family have been reported to cat-
alyze reactions beyond their native functions, all the reactions re-
ported proceed through the native iron-oxo mechanism13. We hy-
pothesized that non-heme iron enzymes might also be able to cata-
lyze abiological transformations similar to heme-binding proteins 
through a non-natural mechanistic pathway. 
We screened a set of seven purified α-ketoglutarate (αKG)-de-
pendent iron dioxygenases against the intermolecular aziridination 
reaction of styrene 1 and p-toluenesulfonyl azide 2. Aziridination14 
and carbon–hydrogen (C–H) bond insertions of nitrenes15 have 
been reported using engineered heme-binding proteins and were 
subsequently proposed in a natural product biosynthetic pathway16. 
Chang et al. speculated the existence of a transient iron-nitrene in-
termediate in their report of the transformation of alkyl azides to 
nitriles by an αKG-dependent iron dioxygenase, but this reaction 
still proceeds through the canonical iron-oxo catalytic cycle13b. To 
date, no reported non-heme iron enzyme, natural or engineered, has 
been reported to catalyze productive nitrene transfer.  
From the set of enzymes we tested, only Pseudomonas savas-
tanoi ethylene-forming enzyme (PsEFE, UniProt ID P32021), 
formed aziridine 3 significantly above background (Supplementary 
Table S2). Compared to other members of the αKG-dependent iron 
dioxygenase family PsEFE is mechanistically and structurally dis-
tinct. While most enzymes of this family catalyze the oxidation of 
a substrate, often C–H hydroxylation, PsEFE natively catalyzes the 
fragmentation of the usual co-substrate α‑ketoglutarate to ethylene, 
as well as the hydroxylation of L-arginine17. Structurally, PsEFE 
possesses a hybrid fold, combining elements of both type I and 
type II αKG-dependent iron enzymes. It binds α-ketoglutarate in a 
strained conformation in an unusually hydrophobic pocket, which 
is likely responsible for the atypical catalytic activity18. 
As the iron-binding site in PsEFE is quite unlike that of the 
heme-binding proteins that perform nitrene-transfer chemistry, we 
sought to characterize the necessary components of the reaction. 
Iron is required, with a single added equivalent of iron(II) sufficient 
to fully restore catalytic activity of the wild-type apoenzyme.  
PsEFE has three coordination sites filled by amino-acid side chains 
(two histidines and one aspartate), leaving up to three additional 
sites open for binding. In the native catalytic mechanism of PsEFE 
and other members of its family, α-ketoglutarate occupies two of 
these sites and is required for activity, as it is oxidatively decarbox-
ylated to succinate to generate the reactive iron-oxo intermediate. 
PsEFE has been shown to catalyze arginine hydroxylation with α-
ketoadipate instead of α-ketoglutarate, but with 500-fold lower ac-
tivity. Other α-ketoacids were reported to give no activity19. 
Nitrene transfer, however, does not proceed through the native cat-
alytic cycle and therefore does not require αKG as a co-substrate; 
the αKG is now more a cofactor and as such could potentially be 
replaced by different small-molecule ligands. Intrigued by the pos-
sibility of modulating enzyme activity by changing the primary co-
ordination sphere of the catalytic iron, we tested PsEFE for aziridi-
nation with a set of α-ketoglutarate mimics and related molecules 
as additives. We found that whereas addition of a carboxylate is 
beneficial for activity (though not required), the wild-type enzyme 
is significantly more active for aziridination with added acetate or 
N-oxalylglycine (NOG, a general αKG-dependent enzyme compet-
itive inhibitor11) compared to α-ketoglutarate (Table 1). 
Table 1. Aziridination catalyzed by wild-type PsEFE 
 
Deviation from standard conditions1 Relative activity 
None 1.00 
No iron 0.08 
No αKG 0.52 
Acetate2 instead of αKG 6.72 
N-oxalylglycine3 instead of αKG 7.75 
Acetate instead of αKG, no ascorbic acid 6.01 
1Standard conditions: Reactions were performed in MOPS 
buffer (20 mM pH 7.0) with 5% ethanol co-solvent, with 20 μM 
apoenzyme, 1 mM Fe(NH4)2(SO4)2, 1 mM αKG (as disodium 
salt), 1 mM L-ascorbic acid, and 10 mM 1 and 2. 2Sodium salt. 
3Free acid. 
We then sought to improve PsEFE for aziridination via directed 
evolution, targeting active-site residues with site-saturation muta-
genesis and screening for enhanced activity. During directed evo-
lution, we screened with added acetate, as it enhanced the activity 
of the wild-type enzyme significantly more than the native α-ke-
toglutarate, it is biologically ubiquitous, and it is inexpensive. Alt-
hough α-ketoglutarate is the native cofactor and is naturally present 
at near-millimolar intracellular concentration in Escherichia coli20, 
we reasoned that by supplementing the reaction medium with ace-
tate we could evolve PsEFE to be dependent on acetate instead.  
After two rounds of site-saturation mutagenesis and one round 
of recombination, we found a variant with five mutations from the 
wild type (T97M R171L R277H F314M C317M, PsEFE 
MLHMM) which catalyzed the formation of 3 with 120 total turn-
over number (TTN) and 88% enantiomeric excess (ee) favoring the 
(R)-enantiomer (Figure 2A). Four of the five introduced mutations 
are in the binding pocket of the native substrate arginine and pre-
sumably are involved in substrate binding. The fifth beneficial mu-
tation is at Arg-277, the residue whose guanidino group natively 
binds the distal carboxylate of α-ketoglutarate (Figure 2B). The 
R277H mutation presumably abolishes binding of the native cofac-
tor α-ketoglutarate; as a result, PsEFE MLHMM shows no signifi-
cant increase in aziridination activity when α-ketoglutarate is 
added, but an 11-fold increase when acetate is added (Supplemen-
tary Table S4). Thus the evolved MLHMM variant is more acti-
vated by acetate than the wild type and is no longer activated by α-
ketoglutarate at all, demonstrating the tunability of the cofactor de-
pendence of PsEFE. 
 
     
Figure 2. Directed evolution of PsEFE for aziridination. (A) Evolutionary lineage. Reactions were performed in triplicate anaerobically with 
acetate and quantified by analytical HPLC-UV. Full experimental details are given in the Supporting Information. (B) Structural representa-
tion of PsEFE with mutated sites highlighted in orange; metal-coordinating residues H189, D191, and H268 are represented in sticks and 
Mn (the metal with which the protein was crystallized) is represented as a purple sphere (PDB ID: 6CBA). 
We reasoned that variants of PsEFE generated by directed evo-
lution for aziridination could exhibit promiscuous activity for addi-
tional nitrene-transfer reactions beyond aziridination. Screening a 
panel of variants for the intramolecular C–H bond insertion reac-
tion of 2-ethylbenzenesulfonyl azide 4 to form sultam 5, we identi-
fied multiple variants that perform this reaction with good TTN, 
excellent chemoselectivity, and moderate enantioselectivity. Re-
markably, PsEFE R171V F314M C317M (PsEFE VMM) is signif-
icantly more active and more chemo- and enantioselective with N-
oxalylglycine added than with either acetate or α-ketoglutarate, 
forming 5 with up to 730 TTN and greater than 100:1 selectivity 
for insertion over reduction (Table 2). This chemoselectivity is 
much higher than that of the heme proteins previously reported to 
catalyze similar reactions15a,b. To probe the specific effect of cofac-
tor binding on activity, we tested PsEFE R171V R227H F314M 
C317M (PsEFE VHMM), a variant in which αKG and NOG bind-
ing are disrupted by the R277H mutation. Whereas PsEFE 
VHMM’s activity is still enhanced nearly ten-fold with acetate, 
there is no significant difference between its activity with no addi-
tive, αKG, or NOG added to the reaction (Table 2). αKG or its an-
alogues therefore appear to bind within the native αKG binding 
site, activating the protein through the primary metal coordination 
sphere. 
Aziridination with PsEFE is reasonably oxygen tolerant, with the 
MLHMM variant maintaining 20% activity for aziridination when 
performed in air. C–H insertion, however, does not proceed detect-
ably in aerobic conditions with any variant tested. These observa-
tions suggest that formation of the putative iron-nitrene intermedi-
ate is not significantly inhibited by oxygen, but that a subsequent 
mechanistic step in the C–H insertion reaction is inhibited aerobi-
cally. Unlike nitrene transfer with heme proteins15a, an additional 
reductant is not required when reactions are performed anaerobi-
cally (Supplementary Table S4).  
 
Table 2. Nitrene C–H insertion catalyzed by PsEFE 
 
PsEFE variant Additive TTN (5) ee (%) 5/6 
Wild type Acetate 12 n.d.1 1.6 
VHMM None 27 n.d.1 3.4 
VHMM αKG 31 n.d.1 3.8 
VHMM Acetate 240 7.3 32 
VHMM NOG 33 n.d.1 4.1 
VMM None 25 n.d.1 0.9 
VMM αKG 130 61 9.0 
VMM Acetate 310 9.4 24 
VMM NOG 450 48 105 
VMM2 NOG 730 47 100 
Reactions were performed anaerobically in MOPS buffer 
(20 mM pH 7.0) with 2.5% ethanol co-solvent, 20 μM apoenzyme, 
1 mM Fe(NH4)2(SO4)2, 1 mM additive, 1 mM L-ascorbic acid, and 
10 mM 4 (maximum 500 TTN). Reactions were quantified by ana-
lytical HPLC-UV. TTNs are shown for 5 only. 1Not determined due 
to low conversion. 210 μM enzyme concentration (max. 1000 
TTN). 
PsEFE is highly expressed (>200 mg/L E. coli culture) and is 
catalytically active in whole E. coli cells and in cell lysate. We ob-
serve that in cell lysate the enzyme maintains high activity with no 
external additive; the enzyme presumably retains a cofactor from 
the intracellular environment during lysis. Addition of N-oxalylgly-
cine nevertheless enhances C–H insertion yield and chemoselectiv-
ity when PsEFE VMM is in cell lysate. In whole cells, however, 
A B 
 
there is no significant change upon addition of N-oxalylglycine 
(Supplementary Table S6). This is unsurprising as N-oxalylglycine 
is not reported to be cell-permeable. Future biochemical studies and 
further mutagenesis will likely enhance the selectivity for cofactor 
analogues and impart in vivo activation to PsEFE variants. 
In conclusion, we have discovered a non-heme iron enzyme ca-
pable of performing nitrene-transfer chemistry and enhanced that 
activity via directed evolution. This is the first example of enzy-
matic nitrene transfer catalyzed by a non-heme metalloprotein. 
PsEFE features a metal center whose primary coordination sphere 
can be altered by simple reaction additives, allowing for modula-
tion of catalytic activity and selectivity. We anticipate that this bi-
ocatalytic system will lead to discovery of new metalloenzymatic 
transformations not possible with previously reported enzymes. 
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Notes 
A provisional patent has been filed through the California Institute 
of Technology based on the results presented here. 
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